Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Other Non-Current Liabilities (2016 - 2026)

Avanos Medical's Other Non-Current Liabilities history spans 13 years, with the latest figure at $13.5 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 206.82% to $13.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.5 million, a 206.82% increase, with the full-year FY2025 number at $13.5 million, up 206.82% from a year prior.
  • Other Non-Current Liabilities hit $13.5 million in Q4 2025 for Avanos Medical, down from $20.7 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for AVNS hit a ceiling of $28.0 million in Q1 2022 and a floor of $4.3 million in Q2 2025.
  • Historically, Other Non-Current Liabilities has averaged $14.0 million across 5 years, with a median of $10.8 million in 2021.
  • The widest YoY moves for Other Non-Current Liabilities: up 206.82% in 2025, down 59.05% in 2025.
  • Tracing AVNS's Other Non-Current Liabilities over 5 years: stood at $9.1 million in 2021, then surged by 125.27% to $20.5 million in 2022, then plummeted by 51.22% to $10.0 million in 2023, then crashed by 56.0% to $4.4 million in 2024, then surged by 206.82% to $13.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for AVNS at $13.5 million in Q4 2025, $20.7 million in Q3 2025, and $4.3 million in Q2 2025.